PMA

P240011: Medtronic Altaviva System

FDA PMA · Stimulator, tibial, electrical, implantable, for urinary incontinence · Medtronic Neuromodulation

Key facts

PMA number P240011
Trade name Medtronic Altaviva System
Generic name Stimulator, tibial, electrical, implantable, for urinary incontinence
Applicant Medtronic Neuromodulation
Owner/operator Medtronic, Inc.
Product code QPT
Approval date Sep 18, 2025
Establishment registration 2182207
FEI number 2182207

At a glance

  • 10–99 Supplements
  • Sep 14, 2026 Latest supplement decision
  • No Withdrawn
  • Yes Summary of safety and effectiveness on file
  • 1–9 UDI device identifiers (GUDID)
  • None MAUDE adverse event reports
  • None Recall events

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMA approvals

Premarket approval (PMA) is the FDA's most stringent review pathway, required for most Class III devices that support or sustain life or present a potentially unreasonable risk.

Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date:

Browse all PMA approvals